Overview

The Cardiomyopathy and Cardio-Oncology Symposium is designed to provide a state-of-the-art, comprehensive curriculum that addresses important clinical topics relevant to cardiomyopathy and the cardiovascular health of cancer patients and survivors. Cardio-oncology is an important and emerging field of medicine resulting from new or unexpected cardiovascular toxicities many cancer survivors are now experiencing because of their cancer treatments. In addition, cardiac amyloidosis is a burgeoning disease with exciting new treatments. Nationally recognized faculty in the fields of cardiology and oncology will discuss challenging topics related to common cardiomyopathies as well as current best practices for diagnosing, treating and managing afflicted patients. The goal of the conference is for participants to return to their practice equipped with the latest evidence base and practical information to improve patient care.

Learning Objectives

After attending this live activity, participants should be able to:

• Evaluate current and emerging treatment options for cardiac amyloidosis.
• Discuss diagnosis and treatment considerations for patients with cardiac sarcoidosis.
• Assess the importance of genetic testing and treatment for genetic cardiomyopathies including hypertrophic cardiomyopathy.
• Analyze best practices in the multidisciplinary monitoring and management of cardiac toxicity in patients undergoing cancer therapy.
• Employ management strategies for venous thromboembolism and other cardiovascular complications that may occur in patients with cancer.
• Demonstrate the importance of ongoing cardiac disease monitoring in cancer survivors.

Accreditation

Scripps Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Scripps Health designates this live activity for a maximum of 7.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

For more information please visit the official event page.